nineteen sequential patients admitted for treatment of acute nonlymphocytic leukaemia ( anll ) were managed with a regimen utilizing a 3 d continuous intravenous infusion of daunomycin ( dnm ) , and the complete response rate was similar to this institution 's past experience with antileukaemic regimens employing 3 d bolus dnm .
C0023467
acute nonlymphocytic leukaemia
C0011015
dnm